Trial · NCT01067521
Adverse events714
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 714
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site erythema | General disorders | Delayed Start: GA 40 mg | 107 | 419 | 122 |
| other | Injection site erythema | General disorders | Delayed Start: Placebo | 8 | 461 | 10 |
| other | Injection site erythema | General disorders | Early Start: GA 40 mg / GA 40 mg | 243 | 943 | 391 |
| other | Injection site pain | General disorders | Delayed Start: GA 40 mg | 55 | 419 | 61 |
| other | Injection site pain | General disorders | Delayed Start: Placebo | 10 | 461 | 10 |
| other | Injection site pain | General disorders | Early Start: GA 40 mg / GA 40 mg | 115 | 943 | 138 |
| other | Injection site pruritus | General disorders | Delayed Start: GA 40 mg | 23 | 419 | 24 |
| other | Injection site pruritus | General disorders | Delayed Start: Placebo | 2 | 461 | 2 |
| other | Injection site pruritus | General disorders | Early Start: GA 40 mg / GA 40 mg | 68 | 943 | 95 |
| other | Injection site swelling | General disorders | Delayed Start: GA 40 mg | 23 | 419 | 23 |
| other | Injection site swelling | General disorders | Delayed Start: Placebo | 3 | 461 | 5 |
| other | Injection site swelling | General disorders | Early Start: GA 40 mg / GA 40 mg | 50 | 943 | 95 |
| other | Bronchitis | Infections and infestations | Delayed Start: GA 40 mg | 20 | 419 | 25 |
| other | Bronchitis | Infections and infestations | Delayed Start: Placebo | 7 | 461 | 9 |
| other | Bronchitis | Infections and infestations | Early Start: GA 40 mg / GA 40 mg | 50 | 943 | 65 |
| other | Influenza | Infections and infestations | Delayed Start: GA 40 mg | 25 | 419 | 33 |
| other | Influenza | Infections and infestations | Delayed Start: Placebo | 17 | 461 | 22 |
| other | Influenza | Infections and infestations | Early Start: GA 40 mg / GA 40 mg | 67 | 943 | 103 |
| other | Nasopharyngitis | Infections and infestations | Delayed Start: GA 40 mg | 56 | 419 | 98 |
| other | Nasopharyngitis | Infections and infestations | Delayed Start: Placebo | 39 | 461 | 47 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01067521/events